AvertD: Understanding the DNA Test for Opioid Addiction Risk
In This Article
AvertD, an FDA-approved groundbreaking new type of DNA test, claims to predict a person’s risk for opioid addiction. These tests scan for genetic markers associated with the brain’s reward pathways, which can influence opioid addiction and dependence.
This innovation offers hope for fighting the opioid crisis. However, experts caution that this technology raises potential benefits and serious challenges.
DNA Tests as a Tool for Opioid Addiction Prevention
The potential upside of these genetic tests is substantial. By identifying people with a higher genetic risk, people and their doctors can make proactive, informed decisions to prevent opioid addiction from ever developing.
This could lead to exploring non-opioid pain management options as a first-line treatment, potentially leading to fewer opioid prescriptions and a positive impact on the addiction crisis. Additionally, these tests might pave the way for more personalized addiction treatment plans tailored to a person’s specific genetic makeup.
The Risks and Ethics of DNA Addiction Tests
The uncertainty around these types of DNA tests is understandable. Addiction is a complex disease influenced by both genes and the environment.
Current DNA tests may not offer a foolproof prediction as they have limitations, especially since the studies around AvertD are still in their infancy.
False positive results could lead to unnecessary anxiety and the under-treatment of pain. False negatives, on the other hand, could leave some high-risk patients unknowingly vulnerable.
The Need for Inclusive Data in DNA Tests
There are also ethical concerns about privacy, genetic discrimination, and the potential for these tests to be misused. Most of the genetic data used to develop these tests comes from individuals of European ancestry.
This raises questions about the tests’ accuracy for diverse populations. Underrepresented regions may not benefit from tests that can’t compare their genetic markers with people who share the most genetic overlap with them.
The Importance of a Comprehensive Approach
Experts worry that doctors may place too much emphasis on DNA results, neglecting to thoroughly consider other important risk factors, like family history and mental health conditions.
Both these factors can heavily impact your potential for addiction. Finally, the cost and accessibility of genetic testing may limit their potential impact.
Sponsored
Online Therapy Can Help
Over 3 million people use BetterHelp. Their services are:
- Professional and effective
- Affordable and convenient
- Personalized and discreet
- Easy to start
Answer a few questions to get started
DNA Tests for Addiction Need Further Research
While DNA tests represent a promising new tool, they are not a silver bullet solution to the opioid crisis. Further research is essential to fully understand their accuracy and limitations.
It’s crucial that these tests be used responsibly, in conjunction with a careful assessment of a patient’s overall health and risk profile.
What's Next?
Sponsored
Get matched with an affordable mental health counselor
Find a TherapistAnswer a few questions to get started
